Biotricity, Inc. (BTCY)

USD 0.5

(2.04%)

Total Assets Summary of Biotricity, Inc.

Biotricity, Inc.'s latest annual total assets in 2024 was 5.94 Million USD , down -8.72% from previous year.
Biotricity, Inc.'s latest quarterly total assets in 2024 FY was 5.94 Million USD , down -8.72% from previous quarter.
Biotricity, Inc. reported annual total assets of 6.51 Million USD in 2023, down -60.96% from previous year.
Biotricity, Inc. reported annual total assets of 16.67 Million USD in 2022, up 275.8% from previous year.
Biotricity, Inc. reported quarterly total assets of 6.14 Million USD for 2024 Q1, down -5.63% from previous quarter.
Biotricity, Inc. reported quarterly total assets of 5.94 Million USD for 2024 FY, down -8.72% from previous quarter.

Annual Total Assets Chart of Biotricity, Inc. (2024 - 2014)

Historical Annual Total Assets of Biotricity, Inc. (2024 - 2014)

Year	Total Assets	Total Assets Growth
2024	5.94 Million USD	-8.72%
2023	6.51 Million USD	-60.96%
2022	16.67 Million USD	275.8%
2021	4.43 Million USD	121.41%
2020	2 Million USD	308.51%
2019	490.66 Thousand USD	-47.21%
2018	929.42 Thousand USD	96.28%
2017	473.51 Thousand USD	-8.78%
2016	519.09 Thousand USD	2668.8%
2015	18.74 Thousand USD	0.0%
2014	- USD	0.0%

Year	Total Assets	Total Assets Growth
2024 Q4	5.94 Million USD	8.32%
2024 Q1	6.14 Million USD	-5.63%
2024 FY	5.94 Million USD	-8.72%
2024 Q3	5.48 Million USD	-19.6%
2024 Q2	6.82 Million USD	11.06%
2023 Q2	8.05 Million USD	-33.72%
2023 FY	6.51 Million USD	-60.96%
2023 Q4	6.51 Million USD	-2.05%
2023 Q3	6.64 Million USD	-17.46%
2023 Q1	12.14 Million USD	-27.15%
2022 Q4	16.67 Million USD	-20.75%
2022 FY	16.67 Million USD	275.8%
2022 Q3	21.04 Million USD	50.84%
2022 Q2	13.95 Million USD	404.19%
2022 Q1	2.76 Million USD	-37.65%
2021 FY	4.43 Million USD	121.41%
2021 Q1	1.38 Million USD	-30.7%
2021 Q3	5.13 Million USD	148.57%
2021 Q4	4.43 Million USD	-13.65%
2021 Q2	2.06 Million USD	48.85%
2020 Q3	5.52 Million USD	422.75%
2020 Q1	1.04 Million USD	113.37%
2020 Q4	2 Million USD	-63.75%
2020 FY	2 Million USD	308.51%
2020 Q2	1.05 Million USD	1.03%
2019 FY	490.66 Thousand USD	-47.21%
2019 Q2	419.42 Thousand USD	46.33%
2019 Q1	286.63 Thousand USD	-69.16%
2019 Q4	490.66 Thousand USD	3.71%
2019 Q3	473.09 Thousand USD	12.8%
2018 Q2	667.41 Thousand USD	-46.26%
2018 FY	929.42 Thousand USD	96.28%
2018 Q4	929.42 Thousand USD	-63.88%
2018 Q3	2.57 Million USD	285.51%
2018 Q1	1.24 Million USD	162.26%
2017 FY	473.51 Thousand USD	-8.78%
2017 Q1	109.67 Thousand USD	-31.23%
2017 Q2	84.05 Thousand USD	-23.36%
2017 Q3	67.51 Thousand USD	-19.68%
2017 Q4	473.51 Thousand USD	601.35%
2016 Q1	28 Thousand USD	0.0%
2016 Q2	18.74 Thousand USD	-33.04%
2016 Q3	519.09 Thousand USD	2668.8%
2016 Q4	159.48 Thousand USD	-69.28%
2016 FY	519.09 Thousand USD	2668.8%
2015 FY	18.74 Thousand USD	0.0%
2015 Q2	- USD	0.0%
2014 FY	- USD	0.0%

Peer Total Assets Comparison of Biotricity, Inc.

Name	Total Assets	Total Assets Difference
Acutus Medical, Inc.	53.96 Million USD	88.987%
Cell MedX Corp.	46.12 Thousand USD	-12784.578%
Dynatronics Corporation	25.94 Million USD	77.091%
Nemaura Medical Inc.	14.56 Million USD	59.194%
PetVivo Holdings, Inc.	3.11 Million USD	-90.759%
RetinalGenix Technologies Inc.	156.00 USD	-3809275.0%
Sonendo, Inc.	78.16 Million USD	92.397%
Telesis Bio, Inc.	70.41 Million USD	91.56%
Talis Biomedical Corporation	98.34 Million USD	93.957%
Viveve Medical, Inc.	25.91 Million USD	77.067%